Found: 48
Select item for more details and to access through your institution.
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1570, doi. 10.1007/s10637-020-00910-9
- By:
- Publication type:
- Article
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
- Published in:
- Neurological Research & Practice, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42466-023-00282-4
- By:
- Publication type:
- Article
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00184-x
- By:
- Publication type:
- Article
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
- Published in:
- Neurological Research & Practice, 2022, p. 1, doi. 10.1186/s42466-022-00184-x
- By:
- Publication type:
- Article
Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes:in vitroparadigm of differential neurotoxicity.
- Published in:
- Journal of Neurochemistry, 2004, v. 91, n. 5, p. 1067, doi. 10.1111/j.1471-4159.2004.02774.x
- By:
- Publication type:
- Article
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12170-4
- By:
- Publication type:
- Article
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11846-1
- By:
- Publication type:
- Article
Patterns of Progression in Malignant Glioma Following Anti-VEGF Therapy: Perceptions and Evidence.
- Published in:
- Current Neurology & Neuroscience Reports, 2011, v. 11, n. 3, p. 305, doi. 10.1007/s11910-011-0184-0
- By:
- Publication type:
- Article
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 167, n. 2, p. 245, doi. 10.1007/s11060-024-04595-5
- By:
- Publication type:
- Article
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 2, p. 353, doi. 10.1007/s11060-023-04419-y
- By:
- Publication type:
- Article
Conventional and emerging treatments of astrocytomas and oligodendrogliomas.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 3, p. 471, doi. 10.1007/s11060-022-04216-z
- By:
- Publication type:
- Article
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 483, doi. 10.1007/s11060-021-03716-8
- By:
- Publication type:
- Article
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 533, doi. 10.1007/s11060-016-2206-x
- By:
- Publication type:
- Article
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 373, doi. 10.1007/s11060-014-1644-6
- By:
- Publication type:
- Article
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 117, n. 1, p. 141, doi. 10.1007/s11060-014-1365-x
- By:
- Publication type:
- Article
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 117, n. 1, p. 85, doi. 10.1007/s11060-013-1356-3
- By:
- Publication type:
- Article
Patient, Relative and Staff Experiences of Clinical Trial Participation in Neurooncology: "Maybe You Can Also Show the Positive, No Matter How It Ends".
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 663, doi. 10.2147/CMAR.S447407
- By:
- Publication type:
- Article
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8373, doi. 10.1002/cam4.3447
- By:
- Publication type:
- Article
Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2017, v. 37, n. 2, p. 485, doi. 10.1177/0271678X16630322
- By:
- Publication type:
- Article
Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas.
- Published in:
- European Neurology, 2013, v. 69, n. 2, p. 95, doi. 10.1159/000343811
- By:
- Publication type:
- Article
Treatment of glioblastoma in adults.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418790452
- By:
- Publication type:
- Article
Lung toxicity of lomustine in the treatment of progressive gliomas.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac068
- By:
- Publication type:
- Article
Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 127, doi. 10.1186/1471-2407-11-127
- By:
- Publication type:
- Article
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma.
- Published in:
- Theranostics, 2021, v. 11, n. 19, p. 9217, doi. 10.7150/thno.60679
- By:
- Publication type:
- Article
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2820, doi. 10.3390/cancers12102820
- By:
- Publication type:
- Article
Automated brain extraction of multisequence MRI using artificial neural networks.
- Published in:
- Human Brain Mapping, 2019, v. 40, n. 17, p. 4952, doi. 10.1002/hbm.24750
- By:
- Publication type:
- Article
Rechallenge with temozolomide in patients with recurrent gliomas.
- Published in:
- Journal of Neurology, 2009, v. 256, n. 5, p. 734, doi. 10.1007/s00415-009-5006-9
- By:
- Publication type:
- Article
Bevacizumab does not increase the risk of remote relapse in malignant glioma.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 3, p. 586, doi. 10.1002/ana.22336
- By:
- Publication type:
- Article
Synergistic antiglioma activity of radiotherapy and enzastaurin.
- Published in:
- Annals of Neurology, 2007, v. 61, n. 2, p. 153, doi. 10.1002/ana.21057
- By:
- Publication type:
- Article
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 701, doi. 10.1093/neuonc/noad244
- By:
- Publication type:
- Article
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1935, doi. 10.1093/neuonc/noac116
- By:
- Publication type:
- Article
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1667, doi. 10.1093/neuonc/noaa120
- By:
- Publication type:
- Article
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 95, doi. 10.1093/neuonc/noy161
- By:
- Publication type:
- Article
ATIM-35. VXM01 PHASE I STUDY IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA – FINAL RESULTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi9, doi. 10.1093/neuonc/noy148.030
- By:
- Publication type:
- Article
ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi8, doi. 10.1093/neuonc/noy148.028
- By:
- Publication type:
- Article
Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 11, p. 1517, doi. 10.1093/neuonc/noy134
- By:
- Publication type:
- Article
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 848, doi. 10.1093/neuonc/nox188
- By:
- Publication type:
- Article
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation--the NCT Neuro Master Match (N<sup>2</sup>M<sup>2</sup>) pilot study.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 826, doi. 10.1093/neuonc/nox216
- By:
- Publication type:
- Article
Glioblastoma in elderly patients: solid conclusions built on shifting sand?
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 175, doi. 10.1093/neuonc/nox133
- By:
- Publication type:
- Article
ID(H)entifying checkpoint inhibitor candidates among diffuse glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1427, doi. 10.1093/neuonc/nox145
- By:
- Publication type:
- Article
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 12, p. 1673, doi. 10.1093/neuonc/now122
- By:
- Publication type:
- Article
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 11, p. 1529, doi. 10.1093/neuonc/now133
- By:
- Publication type:
- Article
Current status and future directions of anti-angiogenic therapy for gliomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 3, p. 315, doi. 10.1093/neuonc/nov180
- By:
- Publication type:
- Article
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1139, doi. 10.1093/neuonc/nov028
- By:
- Publication type:
- Article
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 1, p. 151, doi. 10.1093/neuonc/nou129
- By:
- Publication type:
- Article
Challenging cytomegalovirus data in glioblastoma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 1, p. 165, doi. 10.1093/neuonc/not212
- By:
- Publication type:
- Article
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 1, p. 92, doi. 10.1093/neuonc/not161
- By:
- Publication type:
- Article
Good maths is needed to understand CMV data in glioblastoma.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 12, p. 2991, doi. 10.1002/ijc.28614
- By:
- Publication type:
- Article